Comparison 1. Pharmacist services targeted at patients versus the delivery of no comparable service.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 % outside blood pressure range	18	4107	Odds Ratio (M‐H, Random, 95% CI)	0.40 [0.29, 0.55]
2 % outside HbA1c range	5	558	Odds Ratio (M‐H, Random, 95% CI)	0.29 [0.04, 2.22]
3 Hospital attendance/admission	14	3631	Odds Ratio (M‐H, Random, 95% CI)	0.85 [0.65, 1.11]
4 Adverse drug effects	3	590	Odds Ratio (M‐H, Random, 95% CI)	1.65 [0.84, 3.24]
5 SF‐36 Physical Functioning	7	1329	Mean Difference (IV, Random, 95% CI)	5.84 [1.21, 10.48]
6 Mortality	9	1980	Odds Ratio (M‐H, Random, 95% CI)	0.79 [0.56, 1.12]
7 HbA1c (%)	15	2298	Mean Difference (IV, Random, 95% CI)	‐0.77 [‐0.97, ‐0.58]
8 Fasting blood glucose (mmol/l)	8	1349	Mean Difference (IV, Random, 95% CI)	‐1.17 [‐1.71, ‐0.63]
9 Diastolic blood pressure (mmHg)	31	5939	Mean Difference (IV, Random, 95% CI)	‐3.50 [‐5.44, ‐1.56]
10 Systolic blood pressure (mmHg)	32	6003	Mean Difference (IV, Random, 95% CI)	‐5.96 [‐7.35, ‐4.57]
11 Total cholesterol (mmol/l)	7	1592	Mean Difference (IV, Random, 95% CI)	‐0.35 [‐0.56, ‐0.13]
12 LDL Cholesterol (mmol/l)	6	854	Mean Difference (IV, Random, 95% CI)	‐0.14 [‐0.30, 0.02]
13 FEV1	3	291	Mean Difference (IV, Random, 95% CI)	0.11 [‐0.01, 0.23]
14 Peak Flow (%)	2	460	Mean Difference (IV, Random, 95% CI)	3.36 [‐0.36, 7.09]
15 Dyspnoea	2	820	Odds Ratio (M‐H, Random, 95% CI)	0.90 [0.68, 1.20]